Neighbourly Pharmacy (NBLY) Stock Price, News & Analysis

Company Overview

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 816,808 shs
• Average Volume: 283,112 shs
• Market Capitalization: C$835.51 million
• P/E Ratio: N/A
• Dividend Yield: 0.98%
• Price Target: N/A
• Consensus Rating: N/A

NBLY Stock Analysis - Frequently Asked Questions

How do I buy shares of Neighbourly Pharmacy?

Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Neighbourly Pharmacy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neighbourly Pharmacy investors own include Bank of Montreal (BMO), Bank of Nova Scotia (BNS), CCL Industries (CCL.B), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Doman Building Materials Group (DBM) and McKesson (MCK).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: TSE:NBLY
• CIK: N/A
• Web: neighbourlypharmacy.ca
• Phone: 416 309 9102
• Fax: N/A
• Employees: 3,648
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.73)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$32.70 million
• Net Margins: -3.74%
• Pretax Margin: N/A
• Return on Equity: -5.34%
• Return on Assets: 0.74%

Debt

• Debt-to-Equity Ratio: 58.29
• Current Ratio: 1.14
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: C$874.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 31.16
• Book Value: C$13.07 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,920,000
• Free Float: N/A
• Market Cap: C$835.51 million
• Optionable: Not Optionable
• Beta: 0.29